In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.
Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during transformation from pre-cancer to cancer, say Stanford Medicine-led team.
Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.
HIV/AIDS researcher David Katzenstein dies
The Stanford virologist conducted clinical vaccine trials, which led to the approval of antiretroviral drugs, greatly improving the survival of people living with HIV Feb 4 2021
David Katzenstein was widely praised for his efforts to bring better, cheaper methodologies to bear on HIV/AIDS prevention and treatment in Africa.
TeachAids
David Katzenstein, MD, professor emeritus of infectious diseases and global health at Stanford Medicine, who spurred advances in diagnosing, treating and preventing AIDS, died Jan. 25 of COVID-19 in Harare, Zimbabwe. He was 69.
Katzenstein was a trained virologist, clinician and tireless advocate for global health. He was widely praised for his energetic push to bring better, cheaper methodologies to bear on HIV/AIDS prevention and treatment in middle- and low-income African countries, where over a 35-year period he spearheaded numerous life-saving projects.
Stanford Medicine launches large-scale surveillance of coronavirus variants in Bay Area
Stanford Medicine researchers are screening diagnostic samples to identify known coronavirus variants circulating in the Bay Area, including those from the United Kingdom, South Africa and Brazil. Jan 21 2021
Benjamin Pinsky is the medical director of the Stanford Clinical Virology Laboratory, where researchers are screening samples for known coronavirus variants circulating in the Bay Area.
Steve Fisch
In March, Stanford Medicine was one of the first academic medical centers in the country to develop a diagnostic test for the novel coronavirus that causes COVID-19. Now, researchers in Stanford’s Clinical Virology Laboratory have developed additional tests to detect the presence of coronavirus variants, or strains, already spreading in the United Kingdom, South Africa, Brazil and some parts of the United States.